TCTR20240312001招募中2 期
Efficacy and safety of the topical isoflavone product on the facial skin in male participants: a randomized controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 Years 至 65 Years（—）
- 性别
- Male
入选标准
- •1. Age between 45-65 years at the screening visit;
- •2. Has a body mass index (BMI) of 18-30 kg/m2;
- •3. Has no reaction to the skin allergy test; and
- •4. Able to read and write Thai.
排除标准
- •1. Has a treatment with estrogen hormone or isoflavones within 6 months prior to the screening visit;
- •2. Has a history of periorificial dermatitis, skin cancer or skin cancer on the face, skin infection, and/or serious comorbidities;
- •3. Has any physical attributes or skin conditions that might interfere with the clear visual (i.e., cuts, sunburn, birth marks, tattoos, extensive scarring, excessive hair growth or acne);
- •4. Uses a drug(s), herb(s), vitamin(s), mineral(s), or dietary supplement(s) and/or other ingredients regularly in the investigational product that may affect the facial skin within 30 days;
- •5. Has a history of hypersensitivity to soy products and/or any other ingredients in the investigational product;
- •6. Uses soy protein isolate, soy protein concentrate, or soy-isoflavone enrichment regularly within 30 days;
- •7. Uses a topical anti-wrinkle treatment course or any aesthetic cosmetic course within 30 days;
- •8. Participates in another clinical trial concurrently or within 30 days prior to the screening visit;
- •9. Has a history of smoking or substance abuse within the past 3 months; and
- •10. Has a history of alcoholism or consumption of pure alcohol > 35 g/day (5 % alcohol) > 710 mL/day, wine (12 % alcohol) > 296 mL/day, or alcoholic beverages (40% alcohol) > 89 mL/day within the past 3 months.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate efficacy and safety of topical administration of timolol maleate 0.5% solution in the treatment of Child Proliferative Hemangioma Early Stage SurfaceChildren Superficial HemangiomaEUCTR2013-005199-17-ESInstitut de Recerca HSCSP70
已完成
3 期
To study the effect of combination of Nadifloxacin 1% + Adapalene 0.1% gel on acneCTRI/2013/05/003616Wockhardt Limited100
招募中
不适用
Efficacy, safety and dose finding trial of topical Jaungo application in atopic dermatitis patients: a randomized, double-blind, placebo-controlled studyKCT0002060Kyung Hee University Oriental Medicine Hospital at Gangdong34
尚未招募
1 期
Evaluation of the efficacy of the formulation of topical anesthesia of Lidocaine / Articaine 4% and Lidocaine / Prilocaine 2.5% with and without Sodium Bicarbonate in the mucosa located posterior to upper canine teethAnxiety DisordersRBR-36y2xgniversidade Federal de Sergipe
进行中（未招募）
不适用
Efficacy and safety of topical steroid/antibiotic association treatments following phacoemulsification cataract extraction - NDEUCTR2006-003305-13-ITSIFI240